Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.6 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |